A novel brain-penetrant oral UGT8 inhibitor decreases in vivo galactosphingolipid biosynthesis in murine Krabbe disease. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.biopha.2022.112808
PubMed Identifier: 35290889
Publication URI: http://europepmc.org/abstract/MED/35290889
Type: Journal Article/Review
Volume: 149
Parent Publication: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 0753-3322